Lidocaine patch 5% for carpal tunnel syndrome: How it compares with injections: A pilot study

Journal of Family Practice

Volumn 55, Issue 3, 2006, Pages 209-214

  Nalamachu, Srinivas ^a   Crockett, R S ^b   Mathur, Deepan ^a  

^a Mid America Physiatrists   (United States)

^b B and B Clinical Innovations   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; LIDOCAINE; METHYLPREDNISOLONE ACETATE;

ADULT; AGED; ARTICLE; BURNING SENSATION; CARPAL TUNNEL SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART PALPITATION; HUMAN; INJECTION SITE PAIN; MALE; NAUSEA; OUTCOMES RESEARCH; PARESTHESIA; PATIENT SATISFACTION; PERIPHERAL NEUROPATHY; PILOT STUDY; POSTHERPETIC NEURALGIA; PROSPECTIVE STUDY; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SINGLE BLIND PROCEDURE; SKIN TINGLING; VOMITING;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; ANTI-INFLAMMATORY AGENTS; CARPAL TUNNEL SYNDROME; DRUG COMBINATIONS; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; LIDOCAINE; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PATIENT SATISFACTION; PILOT PROJECTS; STATISTICS, NONPARAMETRIC;

EID: 33644900464     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Viera AJ. Management of carpal tunnel syndrome. Am Fam Physician 2003; 68:265-272.
2. Marshall S, Tardif G, Ashworth N. Local corticosteroid injection for carpal tunnel syndrome. Cochrane Database Syst Rev 2002; 4:CD001554.
3. Ly-Pen D, Andréu J-L, de Bias G, Sánchez-Olaso A, Millán I. Surgical decompression versus local steroid injection in carpal tunnel syndrome: a one-year, prospective, randomized, open, controlled, clinical trial. Arthritis Rheum 2005; 52:612-619.
4. Kasten SJ, Louis DS. Carpal tunnel syndrome: a case of median nerve injection injury and a safe and effective method for injecting the carpal tunnel. J Fam Pract 1996; 43:79-82.
5. Frederick HA, Carter PR, Littler JW. Injection injuries to the median and ulnar nerves at the wrist. J Hand Surg [Am] 1992; 17:645-647.
6. Tavares SP, Giddins GE. Nerve injury following steroid injection for carpal tunnel syndrome. A report of two cases. J Hand Surg [Br] 1996; 21:208-209.
7. Katz JN, Simmons BP. Clinical practice. Carpal tunnel syndrome. N Engl J Med 2002; 346:1807-1812.
8. Goodyear-Smith F, Arroll B. What can family physicians offer patients with carpal tunnel syndrome other than surgery? A systematic review of nonsurgical management. Ann Fam Med 2004; 2:267-273.
9. Gold MS. Sodium channels and pain therapy. Curr Opin Anaesthesiol 2000; 13:565-572.
10. Gold MS, Weinreich D, Kim C-S, et al. Redistribution of NaV1.8 in uninjured axons enables neuropathic pain. J Neurosci 2003; 23:158-166.
11. Galer BS, Sheldon E, Patel N, et al. Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis. Curr Med Res Opinion 2004; 20:1455-1458.
12. Gammaitoni AR, Alvarez, NA, Galer BS. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol 2003; 43:111-117.
13. Barbano RL, Herrmann DN, Hart-Gouleau S, et al. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol 2004; 61:914-918.
14. Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 2003; 106:151-158.
15. American Association of Electrodiagnostic Medicine, American Academy of Neurology, and American Academy of Physical Medicine and Rehabilitation. Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: summary statement. Muscle Nerve 2002; 25:918-922.
16. Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 2004; 5:133-137.